Morgan Stanley Opti Nose, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Opti Nose, Inc. stock. As of the latest transaction made, Morgan Stanley holds 84,183 shares of OPTN stock, worth $31,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,183

Previous 134,290 37.31%

Holding current value

$31,147

Previous $139,000 59.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.67 - $1.27 $33,571 - $63,635	-50,107 Reduced 37.31%	84,183 $56,000
Q2 2024 Oct 17, 2024	SELL	$0.82 - $1.44 $39,264 - $68,952	-47,884 Reduced 26.28%	134,290 $139,000
Q2 2024 Aug 14, 2024	SELL	$0.82 - $1.44 $39,264 - $68,952	-47,884 Reduced 26.28%	134,290 $139,000
Q1 2024 Oct 17, 2024	BUY	$1.17 - $1.94 $56,024 - $92,894	47,884 Added 35.66%	182,174 $265,000
Q1 2024 Aug 16, 2024	SELL	$1.17 - $1.94 $64,500 - $106,950	-55,129 Reduced 23.23%	182,174 $265,000
Q1 2024 May 15, 2024	SELL	$1.17 - $1.94 $64,500 - $106,950	-55,129 Reduced 23.23%	182,174 $265,000
Q4 2023 Aug 16, 2024	BUY	$1.02 - $1.47 $105,073 - $151,429	103,013 Added 76.71%	237,303 $306,000
Q4 2023 Feb 13, 2024	BUY	$1.02 - $1.47 $42,949 - $61,897	42,107 Added 21.57%	237,303 $306,000
Q3 2023 Nov 15, 2023	SELL	$0.93 - $1.38 $82,910 - $123,028	-89,151 Reduced 31.35%	195,196 $240,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.05 $106,699 - $197,058	96,126 Added 51.07%	284,347 $349,000
Q1 2023 May 15, 2023	BUY	$1.63 - $2.02 $97,185 - $120,438	59,623 Added 46.36%	188,221 $363,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.7 $78,365 - $172,590	46,646 Added 56.92%	128,598 $237,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $10,849 - $12,683	-3,163 Reduced 3.72%	81,952 $300,000
Q2 2022 Oct 27, 2022	SELL	$1.76 - $3.82 $293,147 - $636,263	-166,561 Reduced 66.18%	85,115 $312,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.82 $293,147 - $636,263	-166,561 Reduced 66.18%	85,115 $312,000
Q1 2022 Oct 27, 2022	BUY	$1.77 - $2.93 $294,812 - $488,023	166,561 Added 195.69%	251,676 $621,000
Q1 2022 May 13, 2022	SELL	$1.77 - $2.93 $9,819 - $16,255	-5,548 Reduced 2.16%	251,676 $621,000
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $108,566 - $217,133	-70,043 Reduced 21.4%	257,224 $417,000
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.16 $769,077 - $1.03 Million	327,267 New	327,267 $982,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $30.8M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account